A Prospective, Multi-center Registry to Evaluate Safety and Efficacy of Hativ® ELectrocardiogram Monitoring on Patients with Hemodialysis

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT06688565

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06688565
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06688565. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-05-13 (actual); primary completion 2025-05-13 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Prospective, Multi-center Registry to Evaluate Safety and Efficacy of Hativ® ELectrocardiogram Monitoring on Patients with Hemodialysis
Condition
End-Stage Kidney Disease
Condition
Hemodialysis
Intervention (Device)
Hativ® electrocardiogram monitoring
Lead sponsor
Hallym University Medical Center (class: other)

Record details

Record id
cardio:ct-nct06688565
Content hash
5047f8a00eb20b0792d0c8564e5d7bac8f02b46ebb667b64ac5e8fcf89049619